US Stock Movement: Fresenius Medical fell sharply on October 7 — trading suspended pending news, China exit, and rating downgrade

Fresenius Medical Care October 7 Sharp Decline Analysis

Keywords: Trading halt pending news, China exit, Rating downgrade

1. On October 7, 2026, Fresenius Medical Care stock trading was suspended pending news. After trading resumed, the stock fell by about 6%. Available information has not disclosed the specifics of the upcoming announcement, so it is not possible to confirm any new fundamental negative factors.

2. On September 25, 2026, the company announced its exit from the peritoneal dialysis business in China, the cessation of local production and sales of the 4008A hemodialysis system, and expects to recognize related one-off costs in the third quarter of 2026.

3. On September 29, 2026, Berenberg downgraded the company’s rating from “Buy” to “Hold” and lowered the target price from $34.50 to $24.

(Disclaimer: This content is generated by AI technology based on publicly available information and is for reference only. It does not constitute investment advice.)